This important study describes a deep learning framework that analyzes single-cell RNA data to identify a tumor-agnostic gene signature associated with brain metastases. The identified signature ...
Researchers at the University of Eastern Finland and their international collaborators have identified key developmental and ...
Strong clinical data doesn’t just move share prices – it can unlock lucrative global licensing deals for ASX-listed ...
8th-grade students of the European Turkish Lyceum visited the Institute of Biophysics.
Breast cancer is the most common cancer among women in Sri Lanka. Annually, out of approximately 37,000 newly diagnosed ...
Researchers at the University of Eastern Finland and their international collaborators have identified key developmental and ...
Subcutaneous injections of an investigational, selective long-acting amylin receptor agonist led to clinically meaningful reductions in body weight among adults with obesity, a phase II randomized ...
LYL273 has demonstrated a 67% overall response rate, an 83% disease control rate, and a manageable safety profile at the ...
RespireRx Pharmaceuticals Inc. ('RespireRx” or the 'Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal ...
Zealand Pharma Announces Financial Results for the First Nine Months of 2025 With petrelintide advancing at full speed and ...